Stéphane Wilzius

Stéphane Wilzius is a seasoned professional in the pharmaceutical industry, currently serving as the Head of Clinical Operations a.i. at Santhera Pharmaceuticals since January 2025. Prior to this role, Stéphane held the position of Sr. Director of International Clinical Operations at Exact Sciences from January 2022 to December 2024. Stéphane's extensive experience also includes serving as Head of Hematology and Cell Therapy Late Stage Clinical Operations at Bristol Myers Squibb between January 2020 and December 2022, and as Sr. Director of Global Medical Affairs Operations at Celgene from January 2019 to December 2020. Beginning in January 2014 and continuing to December 2018, Stéphane directed Global Clinical Programs at Shire Pharmaceuticals. Stéphane's academic qualifications include two MSc degrees from the University of Montpellier, one in Clinical Data Management and another in Clinical Research and Development.